Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502240263

Apexbio Technology LLC Firategrast 402567-16-2 5mg
SDP

Catalog No. 502240263
Encompass_Preferred

Firategrast (CAS 402567-16-2) is a small-molecule antagonist targeting integrins 4 1 and 4 7 It is designed to block integrin-ligand interactions thereby modulating leukocyte trafficking across the vascular endothelium into tissues Firategrast exerts its biological activity primarily through inhibition of leukocyte adhesion and migration particularly suppressing cell entry into the central nervous system (CNS) Based on these pharmacological properties Firategrast holds research potential in the treatment of relapsing-remitting multiple sclerosis (MS) by reducing CNS inflammation via inhibition of leukocyte infiltration

This item is not returnable. View return policy
Catalog No. 50-224-0263 Supplier Apexbio Technology LLC Supplier No. A34155
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Firategrast (CAS 402567-16-2) is a small-molecule antagonist targeting integrins 4 1 and 4 7 It is designed to block integrin-ligand interactions thereby modulating leukocyte trafficking across the vascular endothelium into tissues Firategrast exerts its biological activity primarily through inhibition of leukocyte adhesion and migration particularly suppressing cell entry into the central nervous system (CNS) Based on these pharmacological properties Firategrast holds research potential in the treatment of relapsing-remitting multiple sclerosis (MS) by reducing CNS inflammation via inhibition of leukocyte infiltration

This item is not returnable. View return policy
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.